Stephane Champiat Selected Research

Stephane Champiat Research Topics

21	Neoplasms (Cancer) 05/2024 - 03/2015
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2020 - 03/2015
3	Hepatitis 01/2019 - 01/2018
1	Esophageal Neoplasms (Esophageal Cancer) 05/2024
1	Esophageal Squamous Cell Carcinoma 05/2024
1	Myocarditis (Carditis) 01/2023
1	Obesity 01/2023
1	Pleural Effusion (Pleural Effusions) 01/2023
1	Weight Loss (Weight Reduction) 01/2023
1	Hepatocellular Carcinoma (Hepatoma) 09/2022
1	Exanthema (Rash) 01/2022
1	Fatigue 01/2022
1	Colorectal Neoplasms (Colorectal Cancer) 01/2020
1	HIV Infections (HIV Infection) 01/2020
1	Breast Neoplasms (Breast Cancer) 01/2020
1	Acute Liver Failure (Fulminant Hepatic Failure) 01/2019
1	Melanoma (Melanoma, Malignant) 01/2016
1	Infections 01/2012

9	Immune Checkpoint InhibitorsIBA 05/2024 - 03/2015
3	Monoclonal AntibodiesIBA 01/2023 - 01/2016
3	LigandsIBA 01/2022 - 11/2018
2	atezolizumabIBA 05/2024 - 01/2022
2	pembrolizumabIBA 01/2023 - 02/2019
2	CytokinesIBA 01/2023 - 01/2020
1	TroponinIBA 01/2023
1	AMG 757IBA 01/2023
1	Immunoglobulin G (IgG)IBA 01/2023
1	CateninsIBA 01/2023
1	DNA (Deoxyribonucleic Acid)IBA 01/2022
1	NivolumabIBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	Exonucleases (3' 5' Exonuclease)IBA 01/2022
1	emactuzumabIBA 01/2022
1	Long Noncoding RNAIBA 01/2020
1	RNA (Ribonucleic Acid)IBA 01/2020
1	Formaldehyde (Formol)FDA Link 01/2020
1	ParaffinIBA 01/2020
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2018
1	CTLA-4 AntigenIBA 01/2016

12	Immunotherapy 01/2023 - 03/2015
4	Therapeutics 05/2024 - 01/2020
4	Drug Therapy (Chemotherapy) 09/2022 - 11/2018
1	Plasma Exchange 01/2019
1	Highly Active Antiretroviral Therapy (HAART) 01/2012